MTN 024/ IPM 031

Status:Completed
Phase:II
Principal Investigator(s):Beatrice Chen
Objective:This study will evaluate the safety of the dapivirine vaginal ring when inserted once every 4 weeks in postmenopausal women for 12 weeks of product use. Last updated May 16, 2021
Prevention Option(s):Microbicides
Study Design:Double-blind, Randomized
Arms and Assigned Interventions
Description
Mode of DeliveryRing
ARMsExperimental
Results: Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women
Official Code: NCT02010593
Trial Sponsors: IPM, MTN
Start Date
End Date
December 31, 2013
May 31, 2014
Enrollment:96
Age range: 45 Years ↔ 65 Years
Population:Cisgender Women